A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction
Hoffmann-La Roche
Hoffmann-La Roche
Centre Francois Baclesse
Baylor College of Medicine
National Cancer Institute (NCI)
Sotio Biotech Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Seagen Inc.
Astellas Pharma Inc
Astellas Pharma Inc
National Cancer Institute (NCI)
AstraZeneca
Takeda
University of Washington
Stanford University
Merck Sharp & Dohme LLC
Cedars-Sinai Medical Center
Merck Sharp & Dohme LLC
Elevation Oncology
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Dana-Farber Cancer Institute
Royal Marsden NHS Foundation Trust
Vedanta Biosciences, Inc.
Leap Therapeutics, Inc.
Taiho Oncology, Inc.
Dartmouth-Hitchcock Medical Center
Hanmi Pharmaceutical Company Limited
Sanofi
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Bristol-Myers Squibb
Incyte Corporation
Ruijin Hospital
Mayo Clinic
MacroGenics
NGM Biopharmaceuticals, Inc
Aprea Therapeutics
Imugene Limited
Hutchmed
University of Athens
Black Diamond Therapeutics, Inc.
National Cancer Center Hospital East
Duke University
Kymab Limited
Taiho Oncology, Inc.
MacroGenics
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)